While apsirin was known to have some positive effects on cardiovascular diseases, a latest study said the decades-old wonder drug can also slow down, if not eliminate, emphysema lung disease.
Emphysema, triggered by smoking cigarettes, damages the air sacs (alveoli) in your lungs, leading to shortness in breathing and finally turning fatal. It is one of several lung diseases known collectively known as chronic obstructive pulmonary disease (COPD).
Treatment may slow the progression of emphysema, but it can’t reverse the damage, according to Mayo Clinic listing on the disease. Now, a new study found that a regular use of aspirin may also slow down the progress of emphysema.
Carrie Aaron from the Columbia University said,”In our large general population sample, we found that using aspirin three or more days per week was associated with a slower progression of percent emphysema on computed tomography (CT) scans over 10 years.”
Based on their study of 4,471 individuals in a Multi-Ethnic Study of Atherosclerosis Lung Study, the researchers measured the percentage of lung volume with emphysematous features with four CT scans every 10 years. In addition, spirometry, a measure of expiratory airflow, was performed in 81% of the participants.
Lead Researcher Carrie Aaron said the results clearly showed that participants who were taking aspirin regularly had a slower progression of emphysema in the last years compared to those who did not.
Though the difference could not be explained in details by many factors, she said, “We believe its affects progression of emphysema.” The paper was part of the 2015 American Thoracic Society International Conference presentations.